COPD Medication Study, Rush University Medical Center, Chicago, Illinois



Adolescent Medicine Allergy and Immunology Pulmonary Critical Care



Allergy & Asthma Allergy, Asthma, & Immunology (Pediatrics) Pediatric Arthritis & Other Rheumatic Diseases (Pediatrics)


Allergy & Immunology Pulmonary & Critical Care Medicine




Angioedema Study Moderate to Severe Persistent Asthma Study Postsurgical Chronic Sinusitis

COPD Medication Study

Clinical Trial Protocol ID
04111511

Clinical Trial Investigator Name
James Moy, MD

Clinical Trial Title
Efficacy and safety study of an investigational drug in patients with chronic obstructive pulmonary disease (COPD)

Clinical Trial Protocol Description

The goal of the study is to evaluate the safety and efficacy of a combination investigational drug for maintenance treatment. The study involves eight clinic visits over a period of 12 months.

Clinical Trial Eligibility CriteriaYou may be eligible to participate in this study if you:

Are over 40 years of age
Have a clinical diagnosis of COPD with symptoms for more than two years
Currently smoke, or have smoked in the past

This is a partial list of eligibility requirements.

Contact Name	Rahab Gandy
Contact Phone	(312) 563-2647
Contact E-mail	clinical_trials@rush.edu



Clinical Trials Home Respiratory Disorders Trials COPD Medication Study